← Back to headlines
Hims & Hers Stock Falls After FDA Advisors Snub First Peptide
Shares of Hims & Hers declined following a decision by FDA advisors regarding the company's first peptide product.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Volkswagen Approves Restructuring Plan to Cut 100,000 Jobs by 2030
46m ago
Trump Administration Seeks Supreme Court Approval for Mail Ballot Restrictions
1h ago
New US-Venezuela Oil Agreement Draws Sharp Criticism and Economic Skepticism
1h ago
Crusoe Secures $3 Billion Funding and Lands $13 Billion Cloud Deal
1h ago